title: Natalizumab and the development of extensive brain lesions in neuromyelitis optica.
authors.forename: Maciej
authors.initials: M
authors.lastname: Juryńczyk
authors.forename: Krzysztof
authors.initials: K
authors.lastname: Zaleski
authors.forename: Krzysztof
authors.initials: K
authors.lastname: Selmaj
mesh_terms: D000328:Adult; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects* / Q000627:therapeutic use; D001921:Brain / Q000187:drug effects* / Q000473:pathology; D001927:Brain Diseases / Q000139:chemically induced* / Q000473:pathology; D005260:Female; D006801:Humans; D000069442:Natalizumab; D009471:Neuromyelitis Optica / Q000188:drug therapy* / Q000473:pathology
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000069442:Natalizumab